Reference
Senapati J, et al. Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country. Leukemia and Lymphoma 62: 1514-1517, No. 6, Jan 2021. Available from: URL: http://doi.org/10.1080/10428194.2020.1867724
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1866, 47 (2021). https://doi.org/10.1007/s40278-021-99743-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-99743-6